Twitter

19. PTC: Links to on-line resources

There are many resources available on-line about all aspects of cancer (fewer specifically devoted to post-transplant risks, but other information would be applicable), some of which are listed here:

Cancer researchersCancer general resources:

Cancer articles of interest:

Cancer in Transplant Recipients

Immunosuppressant drugs:

  • Calcineurin inhibitors:
    Gengraf, Neoral,  Sandimmune (generic name: cyclosporine)
    Hecoria, Prograf, Astagraf XL (generic name: tacrolimus)

  • mTOR inhibitors:
    Afinitor, Afinitor Disperz, Zortress (generic name: everolimus)
    Torisel (generic name: temsirolimus)
    Rapamune (generic Name: sirolimus)

Skin cancer resources:

Kidney cancer resources:

Financing for Fighting Cancer

Blood cancer resources:

Immunosuppression/Immunodeficiency and Cancer

 Publications from the Transplant Cancer Match Study

(click on title above to learn more about this collaborative study tha tproduced the papers list below)

  1. Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Risk of myeloid neoplasms after solid organ transplantation. Leukemia. 2014 Dec;28(12):2317-23.
  2. Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA. Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol. 2014 Oct;25(10):2335-41.
  3. Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA. Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.
  4. Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol. 2014 Jul;89(7):714-20.
  5. Engels EA, Castenson D, Pfeiffer RM, Kahn A, Pawlish K, Goodman MT, Nalesnik MA, Israni AK, Snyder J, Kasiske B. Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant. 2014 Jun;14(6):1376-82.
  6. Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients. Haematologica. 2014 May;99(5):70-3.
  7. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013 Dec;13(12):3202-9.
  8. Hall EC, Engels EA, Montgomery RA, Segev DL. Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation. 2013 Sep 15;96(5):476-9.
  9. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013 Jul 9;109(1):280-8.
  10. Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM. Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant. 2013 Jun;13(6):1523-32.
  11. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013 Jun 15;119(12):2300-8.
  12. Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol. 2013 Apr;88(4):245-50.
  13. Hall EC, Segev DL, Engels EA. Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant. 2013 Mar;13(3):714-20.
  14. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011 Nov 2;306(17):1891-901.

Click image to return to navigator site map
 2nd version 894 by 691

DISCLAIMER: The content of this TRIO post-transplant cancer Web site is not influenced by sponsors. The site is designed primarily for use by transplant recipients and their supporters. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your transplant team or a physician skilled in cancer and your organ type if you suspect you are ill.

Transplant Recipients International Organization, Inc.

7055 Heritage Hunt DR, #307
Gainesville VA 20155

800-TRIO-386  (800-874-6386)
info@trioweb.org

Contact TRIO

E-Newsletter Subscribe

First Name:*
Invalid Input

Last Name:*
Invalid Input

Email Address:*
Invalid Input

Support Trio

You can help TRIO by:

Donating time or money, becoming a chapter member or member-at-large, registering as an organ donor, or donating your UAL frequent flyer miles - contact TRIO at info@trioweb.org for more information

Donate Now  About TRIO